GAMMA Investing LLC Has $14.25 Million Holdings in Kenvue Inc. (NYSE:KVUE)

GAMMA Investing LLC grew its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 3,092.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 594,176 shares of the company's stock after acquiring an additional 575,567 shares during the quarter. GAMMA Investing LLC's holdings in Kenvue were worth $14,248,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. SRS Capital Advisors Inc. boosted its position in Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares during the period. Asset Planning Inc acquired a new position in Kenvue during the 4th quarter worth $42,000. Clarity Asset Management Inc. acquired a new position in Kenvue during the 4th quarter worth $45,000. SBI Securities Co. Ltd. acquired a new position in Kenvue during the 4th quarter worth $46,000. Finally, Deseret Mutual Benefit Administrators boosted its position in Kenvue by 29.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock worth $54,000 after acquiring an additional 568 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Evercore ISI assumed coverage on Kenvue in a report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective for the company. Citigroup upped their price objective on Kenvue from $22.00 to $24.50 and gave the company a "neutral" rating in a report on Friday, May 9th. Barclays upped their price objective on Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a report on Monday, May 12th. Redburn Atlantic assumed coverage on Kenvue in a report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective for the company. Finally, Canaccord Genuity Group upped their price objective on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a report on Wednesday, March 5th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and a consensus target price of $25.33.

Kenvue Trading Up 0.4%

Shares of NYSE KVUE traded up $0.08 during mid-day trading on Friday, hitting $21.73. 9,670,463 shares of the company traded hands, compared to its average volume of 16,355,525. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $25.17. The stock has a market capitalization of $41.69 billion, a price-to-earnings ratio of 41.00, a PEG ratio of 2.62 and a beta of 0.98. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average of $23.12 and a two-hundred day moving average of $22.58.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. The firm had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The business's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.28 EPS. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were paid a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.77%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue's dividend payout ratio is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.